Staff at a Glenrothes cable company have been scaling new heights to raise £2050 for two charities close to their hearts.
Employees at Virgin Media, based in Bankhead Industrial Estate, attempted to climb Ben Nevis near Fort William in June to collect money for Action Duchenne and Rachel House.
They didn’t manage to complete the climb due to bad weather conditions, but were pleased to collect £1025 for each charity.
Action Duchenne is the only national charity that exclusively funds research for a cure and promotes campaigns for better medical care for Duchenne and Becker Muscular Dystrophy.
The charity, set up in 2001, raises funds to pay for research into Duchenne Muscular Dystrophy, which is a very severe muscle wasting disease.
There is no cure for the condition and as well as research, money collected by the charity goes to help those affected to help give them a better standard of living.
The fundraiser was organised by Virgin Media staff member Scott Morgan. This is the fourth year he has organised a fundraiser for Action Duchenne.
Scott said: “This year we decided to split the monies between Action Duchenne and Rachel House. The events previously have consisted of water rafting, rock climbing and canyoning. Ben Nevis seemed a great idea and a much tougher challenge.
“We were showing our support for our colleague’s son who suffers from the condition Duchenne.
“We have always raised a minimum of £1000 in previous events so to more than double that figure is very rewarding and I am very proud of our efforts overall.”
Unfortunately the group couldn’t complete the climb due to adverse weather conditions, but Scott added: “On finding out how much money we raised after the event, it certainly eased the disappointment.
“A few of us are going to try and climb it again later this year.”
About Duchenne muscular dystrophy
Duchenne muscular dystrophy is the most common fatal genetic disorder diagnosed in childhood.
The Duchenne gene is found on the X-chromosome, so it primarily affects boys.
Duchenne results in progressive loss of strength and is caused by a mutation in the gene that encodes for dystrophin.
As dystrophin is absent, the muscle cells are easily damaged.
The progressive muscle weakness leads to serious medical problems, particularly relating to the heart and lungs.
Young men with Duchenne typically live into their late 20s.
Life expectancy is improving as standards of care and knowledge about Duchenne increases and some men live into their 30s and 40s.
Although there are medical treatments that may help slow its progression, there is currently no cure for Duchenne.
Action Duchenne is a UK charity founded in 2001 to fund research to find a cure or viable treatments for Duchenne Muscular Dystrophy.